Announced today the closing of a substantial funding round nitric oxide.

Avinger closes significant financing circular to initiate clinical trial on peripheral atherectomy catheter Avinger, Inc nitric oxide here . Producer of therapeutic gadgets incorporating intravascular imaging and pioneer of the lumivascular method of treating vascular disease, announced today the closing of a substantial funding round. Both new and also existing traders participated in the funding. We have been very delighted with the outcome of the latest capital raise, to aid what we anticipate to become a very successful medical trial of Pantheris, the first-ever peripheral atherectomy catheter that also includes intravascular imaging technology using Optical Coherence Tomography , stated Kenneth Novack, Chairman of Avinger's Board of Directors.